SYRE filings
Corporate insider profile
Cameron Turtle Filing Activity
Latest reported as Chief Executive Officer of Spyre Therapeutics, Inc. (SYRE).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$2,126,992.50
- Latest transaction
- Jun 1, 2026
Affiliated corporations
Reported company relationships
Transaction history
